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Abstract: Background
Reports of ethnic inequalities in COVID-19 outcomes are conflicting and the reasons
for any differences in outcomes are unclear. We investigated ethnic inequalities in
critical care admission patterns, the need for invasive mechanical ventilation (IMV), and
in-hospital mortality, among hospitalised patients with COVID-19.
Methods
We undertook a prospective cohort study in which dedicated research staff recruited
hospitalised patients with suspected/confirmed COVID-19 from 260 hospitals across
England, Scotland and Wales, collecting data directly and from records between 6th
February and 8th  May 2020 with follow-up until 22nd  May 2020. Analysis used
hierarchical regression models accounting for confounding, competing risks, and
clustering of patients in hospitals. Potential mediators for death were explored with a
three-way decomposition mediation analysis.
Findings
Of 34,986 patients enrolled, 30,693 (88%) had ethnicity recorded: South Asian (1,388,
5%), East Asian (266, 1%), Black (1,094, 4%), Other Ethnic Minority (2,398, 8%)
(collectively Ethnic Minorities), and White groups (25,547, 83%). Ethnic Minorities were
younger and more likely to have diabetes (type 1/type 2) but had fewer other
comorbidities such as chronic heart disease or dementia than the White group. No
difference was seen between ethnic groups in the time from symptom onset to hospital
admission, nor in illness severity at admission.
Critical care admission was more common in South Asian (odds ratio 1.28, 95%
confidence interval 1.09 to 1.52), Black (1.36, 1.14 to 1.62), and Other Ethnic Minority
(1.29, 1.13 to 1.47) groups compared to the White group, after adjusting for age, sex
and location. This was broadly unchanged after adjustment for deprivation and
comorbidities. Patterns were similar for IMV.
Higher adjusted mortality was seen in the South Asian (hazard ratio 1.19, 1.05 to 1.36),
but not East Asian (1.00, 0.74 to 1.35), Black (1.05, 0.91 to 1.26) or Other Ethnic
Minority (0.99, 0.89 to 1.10) groups, compared to the White group. 18% (95% CI, 9% to
56%) of the excess mortality in South Asians was mediated by pre-existing diabetes.
Interpretation
Ethnic Minorities in hospital with COVID-19 were more likely to be admitted to critical
care and receive IMV than Whites, despite similar disease severity on admission,
similar duration of symptoms, and being younger with fewer comorbidities. South
Asians are at greater risk of dying, due at least in part to a higher prevalence of pre-
existing diabetes.
Funding
National Institute for Health Research and Medical Research Council.
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Summary 
 
Background 
Reports of ethnic inequalities in COVID-19 outcomes are conflicting and the reasons for any differences in 
outcomes are unclear. We investigated ethnic inequalities in critical care admission patterns, the need for 
invasive mechanical ventilation (IMV), and in-hospital mortality, among hospitalised patients with COVID-19. 
Methods 
We undertook a prospective cohort study in which dedicated research staff recruited hospitalised patients 
with suspected/confirmed COVID-19 from 260 hospitals across England, Scotland and Wales, collecting data 
directly and from records between 6th February and 8th May 2020 with follow-up until 22nd May 2020. 
Analysis used hierarchical regression models accounting for confounding, competing risks, and clustering of 
patients in hospitals. Potential mediators for death were explored with a three-way decomposition 
mediation analysis. 
Findings 
Of 34,986 patients enrolled, 30,693 (88%) had ethnicity recorded: South Asian (1,388, 5%), East Asian (266, 
1%), Black (1,094, 4%), Other Ethnic Minority (2,398, 8%) (collectively Ethnic Minorities), and White groups 
(25,547, 83%). Ethnic Minorities were younger and more likely to have diabetes (type 1/type 2) but had 
fewer other comorbidities such as chronic heart disease or dementia than the White group. No difference 
was seen between ethnic groups in the time from symptom onset to hospital admission, nor in illness 
severity at admission.  
Critical care admission was more common in South Asian (odds ratio 1.28, 95% confidence interval 1.09 to 
1.52), Black (1.36, 1.14 to 1.62), and Other Ethnic Minority (1.29, 1.13 to 1.47) groups compared to the 
White group, after adjusting for age, sex and location. This was broadly unchanged after adjustment for 
deprivation and comorbidities. Patterns were similar for IMV.  
Higher adjusted mortality was seen in the South Asian (hazard ratio 1.19, 1.05 to 1.36), but not East Asian 
(1.00, 0.74 to 1.35), Black (1.05, 0.91 to 1.26) or Other Ethnic Minority (0.99, 0.89 to 1.10) groups, compared 
to the White group. 18% (95% CI, 9% to 56%) of the excess mortality in South Asians was mediated by pre-
existing diabetes.  
Interpretation 
Ethnic Minorities in hospital with COVID-19 were more likely to be admitted to critical care and receive IMV 
than Whites, despite similar disease severity on admission, similar duration of symptoms, and being younger 
with fewer comorbidities. South Asians are at greater risk of dying, due at least in part to a higher prevalence 
of pre-existing diabetes. 
Funding 
National Institute for Health Research and Medical Research Council.  
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Research in Context 
Evidence before this study: 
Evidence is emerging of an association between ethnicity and increased mortality in patients with COVID-19, 
as shown in a rapid evidence review by McQuillan et al. In a cohort study on the relative risk of COVID-19 
infection by ethnic group, Niedzwiedz et al linked UK Biobank data to show that Black (relative risk 4.01 [95% 
confidence interval 2.92 to 5.12]), South Asians (2.11 [1.43 to 3.10]) and White Irish (1.60 [1.08 to 2.38]) 
were more likely to have confirmed infection and were more likely to be hospitalised compared to White 
British. This relationship persisted after controlling for socioeconomic deprivation. In another study, de 
Noronha compared actual vs. expected hospital deaths and all ethnic groups other than White British and 
White Irish were found to have an age adjusted excess mortality. The UK Office of National Statistics used 
linked census and mortality records to show that age-adjusted COVID-19 -related death was more four times 
more likely in Black individuals (odds ratio 4.2 [3.81 to 4.63]). When accounting for socioeconomic 
differences, Black (1.93 [1.70 to 2.18]) and Bangladeshi/Pakistani (1.81 [1.55 to 2.11]) individuals were still at 
significantly increased risk of death compared to the White group. The Intensive Care National Audit & 
Research Centre (ICNARC) reported that 33% of patients critically ill with COVID-19 in England, Wales, and 
Northern Ireland are from non-White groups, compared to 12% with non-COVID-19 viral pneumonia in 2017-
19. 
 
Added value of this study 
This is the largest prospective study of patients in hospital with COVID-19. We provide granular data on the 
stark differences in age and levels of comorbidity between White and Ethnic Minority people in hospital with 
COVID-19. We show high levels of use of critical care and invasive mechanical ventilation (IMV) in Ethnic 
Minorities compared with Whites, even after adjustment for age, sex, deprivation, and comorbidities, 
despite similar disease severity at presentation and similar times from symptom onset to hospital admission. 
We found a higher likelihood of death in hospital among South Asians with COVID-19, and for the first time 
show that a significant proportion of this risk was attributable to higher prevalence of diabetes. 
 
Implications of all the available evidence 
These findings have important implications for policy. Ethnicity should be accounted for in the prioritisation 
of prevention treatment and future vaccination policy. South Asians are over-represented in frontline key 
worker and public-interacting occupations, and guidance and policies should take this factor into account. 
Work is on-going to devise risk assessment tools to help mitigate the likelihood of coronavirus infection and 
manage the easing of lockdown restrictions. Careful consideration needs to be given in these tools to the 
weighting of ethnicity and mediators of risk such as diabetes. Further research integrating primary and 
secondary care data is key to improving the understanding of other drivers of poor outcomes among Ethnic 
Minorities.  
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Introduction 
The novel severe acute respiratory syndrome coronavirus SARS-CoV-2 has caused a pandemic, with 5.8 
million reported as infected and over 360,000 reported to have died across the world.1 Studies from China, 
Italy and the UK have consistently reported that advanced age, comorbidity, and male sex are associated 
with increased mortality.2–4  
COVID-19 deaths appear to disproportionately affect people from South Asian and Black ethnic backgrounds, 
but it is unclear if the incidence of infection is greater, the prognosis is worse once infected, or both.5–8 
Patients from Asian, Black and other Minority Ethnic backgrounds are reported to have accounted for 34% of 
COVID-19 admissions to intensive care (ICU) in England, Wales and Northern Ireland, compared with only 
12% for viral pneumonia (2017-2019), and a higher than expected proportion have required organ support 
and have died.9 Of NHS staff known to have died with COVID-19, 63 (63%) were from an ethnic minority 
background.10 In the USA, the mortality rate for Black African Americans is quoted as 2.4 times higher than 
the rate for White Americans.11 It is unclear the extent to which differences in socioeconomic circumstances 
or pre-existing conditions may account for some or all such differences in risk.12  
Ethnicity and socioeconomic position were associated with poor health outcomes during previous 
pandemics.13 The effect of ethnicity on outcome for pandemic influenza 2009 was explained in part by 
socioeconomic status.14 Ethnic minority groups may be at greater risk of infection, severe disease, and poor 
outcomes for multiple reasons. These include socioeconomic conditions that increase risks of transmission 
and vulnerability, such as overcrowded housing,15 employment in essential frontline occupations,16 poverty, 
healthcare seeking behaviours,17 and reliance on public transport.18 People living in more deprived areas in 
the UK have experienced COVID-19 mortality rates more than double those living in less deprived areas.19 
Theoretical biological mechanisms for differences by ethnicity include susceptibility due to common 
comorbid illnesses such as diabetes and cardiovascular disease,20,21 or genetic factors associated with 
susceptibility or disease progression. Susceptibility to infectious disease,22 including influenza,23 and viral 
pneumonia,24 is strongly heritable, and early reports have suggested this is also true for COVID-19.25 Genetic 
variations in factors affecting viral entry26 or the host immune response27 may lead to differential 
susceptibility according to genetic heritage. Behavioural differences by ethnicity may also account for 
variability in healthcare outcomes. 
In the wake of the A/H1N1pdm2009 influenza pandemic, the Clinical Characterisation Protocol UK (CCP-UK) 
for Severe Emerging Infection was developed by the International Severe Acute Respiratory and emerging 
Infections Consortium (ISARIC) and the World Health Organisation. As the pandemic potential of SARS-CoV-2 
became apparent, the CCP was reactivated in the UK on 17th January 2020, in time to recruit the early 
patients admitted to hospitals with COVID-19.4 
Our aim was to assess how prognosis in relation to critical care admission, use of invasive mechanical 
ventilation (IMV), and in-hospital mortality differs by ethnicity in the CCP-UK cohort of hospitalised patients 
with COVID-19. 
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Methods 
Study design and setting  
ISARIC CCP-UK is an ongoing prospective cohort study involving 260 hospitals in England, Scotland, and 
Wales (table E1). The protocol, revision history, case report form, information leaflets, consent forms, and 
detail of the Independent Data and Material Access Committee (IDAMAC) are available at 
https://isaric4c.net. The study was approved by the South Central - Oxford C Research Ethics Committee in 
England (Ref: 13/SC/0149), and by the Scotland A Research Ethics Committee (Ref: 20/SS/0028). The STROBE 
guidelines were used when reporting. 
 
Participants 
Patients were included between 6th February and 8th May 2020 with follow-up until 22nd May 2020. Inclusion 
criteria were people of all ages who were admitted to hospital in England, Scotland, and Wales, with proven 
or a high likelihood of infection with SARS-CoV-2 leading to COVID-19 disease. Reverse transcriptase-PCR 
was the only mode of testing available during the period of study. The decision to test was at the discretion 
of the clinician attending the patient, and not defined by protocol. The enrolment criterion “high likelihood 
of infection” reflected that a preparedness protocol cannot assume a diagnostic test will be available for an 
emergent pathogen. In this activation, site training emphasised importance of only recruiting proven cases. 
 
Data collection 
Data were collected directly and extracted from routine healthcare records by research nurses, 
administrators and medical students, using case report forms on a REDCap (Research Electronic Data 
Capture, https://projectredcap.org) database. With consent, additional biological samples were collected for 
research. Data regarding illness progression and severity, including location within the hospital (ward vs. 
critical care) were collected on days 1 (admission/diagnosis), 3, 6, and 9, and on discharge/death, with 
further daily data collected on consented patients. 
Self-reported ethnicity was transcribed from the healthcare record, where it had been recorded along with 
other demographics on admission. The care report form used an internationally applicable ethnicity 
definition with people categorised into East Asian, South Asian, West Asian, Black, White, Latin American, 
Aboriginal/First Nations and Other ethnic minority.28 For the purposes of this analysis, the collective Ethnic 
Minorities were collapsed into South Asian, East Asian, Black, Other Ethnic Minority (West Asian, Arab, Latin 
American, Aboriginal/First Nations, Other) and White, based on frequency (table E2).  
Recorded comorbidities were asthma, diabetes (type 1 and type 2), chronic cardiac disease (excluding 
hypertension), chronic haematologic disease, chronic kidney disease, chronic neurological disorder, chronic 
pulmonary disease (excluding asthma), dementia, HIV/AIDS, malignancy, malnutrition, mild liver disease, 
moderate/severe liver disease, clinician-assigned obesity, rheumatologic disorder, and smoking.  
As the home address was not available, the Index of Multiple Deprivation (IMD) and equivalents in Scotland 
and Wales, were used to create a hospital-weighted average deprivation score based on the admission 
population. Definitions varied between nations to accommodate data differences. For patients admitted in 
England, a weighted deprivation measure was aggregated by hospital catchment (admissions by Lower Layer 
Super Output Areas [LSOAs] determined from the Hospital Episode Statistics dataset and weighted by the 
relative contribution of each LSOA). For Wales, an average Welsh Index of Multiple Deprivation (WIMD) was 
constructed for each hospital by averaging the 2019 version of the WIMD from all admissions to hospital 
with a pneumonia or flu diagnosis in 2019 (ICD10: J09-J18). For Scotland, a weighted average of the Scottish 
Index of Multiple Deprivation (2018 mid-year data-zone estimates) was made at the hospital level and 
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weighted for all non-elective admissions. To account for differences in the construction of these indices 
across the devolved nations, measures were centred, standardised, and incorporated with a random 
gradient into models. 
 
Outcomes 
The main outcomes were admission to a critical care facility (Intensive Care Unit [level 3] or High 
Dependency Unit [level 2]), use of IMV, and in-hospital mortality. To avoid potential bias in the assessment 
of outcomes where the sickest patients have the longest hospital stays, patients admitted to hospital 
between 8th May and 22nd May 2020 were excluded from outcome analyses.  
As a measure of disease severity at admission, the National Early Warning Score 2 (NEWS2) was used.29 
NEWS2 distributions were compared between groups and medians compared using the Mann-Whitney U 
test. Time from symptom onset to admission was modelled using Cox Proportional Hazards regression.  
 
Statistical analyses 
Continuous data are presented as mean (standard deviation), or median (interquartile range) if substantially 
non-normally distributed. Binary data are presented as frequency (%). Binomial confidence intervals for 
proportions were calculated using Wilson’s method.30 For univariable comparisons, we used Welch’s t, 
ANOVA, Mann–Whitney U, or Kruskal–Wallis tests according to data distribution. Categorical data were 
compared using chi-squared tests. 
Our modelling strategy was informed by a putative causal graphical model (figure E1). Critical care admission 
and IMV use were modelled using hierarchical logistic regression models, adjusting for patient characteristics 
at level 1 and hospital of treatment at level 2. Baseline models included an adjustment for age, sex, and 
location. IMD was aggregated at hospital level, centred, and standardised, and allowed to vary as a random 
gradient by nation (level 3). Associations between ethnicity and comorbidity were modelled individually 
using logistic regression.  
Survival was modelled using Cox Proportional Hazards regression, with alternative methods used for 
sensitivity analyses. Symptom onset was considered time zero. In the primary approach, discharge from 
hospital was considered an absorbing state (once discharged, patients were considered no longer at risk of 
death). Discharged patients were not censored and included in the risk set until the end of follow-up, thus 
discharge did not compete with death. Sensitivity analyses employed Fine & Gray’s competing risks 
method.31 Hierarchical Cox models included hospital as a random intercept and incorporated deprivation 
gradients varying by country. Parsimonious criterion-based model building used the following principles: 
relevant explanatory variables were identified via a causal graph a priori for exploration; age, sex, and 
hospital (random effects) were incorporated in baseline models; interactions were checked at first order 
level; final model selection was informed by the Akaike Information Criterion (AIC) and c-statistic for logistic 
regression models and c-statistic for survival models, with appropriate assumptions checked including the 
distribution of residuals and requirement for proportional hazards. The 30-day model-predicted mortality 
was calculated from the cumulative hazard for particular subgroups of interest and 95% confidence intervals 
determined by bootstrap resampling of models (5000 iterations).  
A classical approach to mediation analysis in survival models was taken, extending into a three-way 
decomposition of total effect into direct, pure indirect, and mediated interactive effects.32 A priori 
hypotheses around the contribution of different comorbidities to mortality were explored, with comorbities 
associated with ethnicity entered into models sequentially. Associations between exposure and outcome, 
mediators and exposure, and mediators and outcome were characterised. Logistic regression models were 
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fitted for mediators and Cox proportional survival models for outcomes, which were then combined. 
Bootstrapping of estimates was performed to provide 95% confidence intervals (95% CIs), together with a 
bootstrapped estimate of the mediated proportion of the total effect. All mediation models included age 
and sex as covariates.  
 
Missing data  
There were substantial levels of missing data due to the challenges of real-time data collection during a 
pandemic. Missing data are reported, and patterns of missing data explored (table E9). Multiple imputation 
of missing values was performed using chained equations for sensitivity analyses. Ten sets, each with 10 
iterations, were imputed using available explanatory variables including the outcome. Missing ethnicity data 
were not imputed, but ethnicity was used in models for imputation. Graphical checks were performed, and 
imputed sets combined using Rubin’s rules.33  
Data were analysed using R (R Core Team v.3.6.3, Vienna, Austria) with packages including tidyverse, finalfit, 
survival, cmprsk, coxme and regmedint. 
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Results 
Between 6th February and 8th May 2020, we enrolled 34,986 patients admitted to 260 hospitals with COVID-
19 in England, Scotland, and Wales. This is estimated to represent 40.4% of all people admitted over that 
time period to hospital with COVID-19 in England, Scotland, and Wales.  
 
Presentation at hospital 
30,693 (88%) had ethnicity data recorded and were considered in the following groups: South Asians 
(n=1,388, 5%), East Asians (266, 1%), Black (1,094, 4%), Other Ethnic Minorities (2,398, 8%), and Whites 
(25,547, 83%) (Figure 1).  
Ethnic Minorities were younger (White mean 72 years (y) [standard deviation 16], South Asian 60 y [17], East 
Asian 60 y [17], Black 61 y [17], Other Ethnic Minority 62 y [18]) and more likely to have diabetes (South 
Asian n=441 [39.4%], East Asian 71 [29.6%], Black 384 [38.8%], Other Ethnic Minority 636 [30.7%]) compared 
to the White group (5838 [25.1%]) (Table 1).  
In unadjusted analysis, Whites were more likely than Ethnic Minorities to have other comorbidities such as 
chronic cardiac disease (White n=8228 [32.2%], South Asian 266 [19.2%], East Asian 47 [17.7%], Black 162 
[14.8%], Other Ethnic Minority 467 [19.5%]; non-asthmatic chronic pulmonary disease (White 4751 [18.6%], 
South Asian 86 [6.2%], East Asian 18 [6.8%], Black 73 [6.7%], Other Ethnic Minority 218 [9.1%]); and 
dementia (White 4106 [16.1%], South Asian 60 [4.3%], East Asian 19 [7.1%], Black 74 [6.8%], Other Ethnic 
Minority 193 [8.0%]).  
With age and sex adjustment, ethnic differences in comorbidity persisted with all Ethnic Minorities more 
likely to have diabetes (type 1 or type 2) and less likely to have non-asthmatic chronic pulmonary disease 
and obesity than the Whites (Figure 2). No difference in the likelihood of chronic cardiac disease was seen 
between South Asians and Whites.  
No significant differences were seen in the distribution of severity scores (national early warning score 2 
[NEWS2]) at admission between ethnic groups (figure 3A and figure 3C). In patients presenting to hospital 
with COVID-19, no differences were seen in the time from symptom onset to admission between ethnic 
groups (figure 3B) when modelled using Cox proportion hazards methods for the relative hazard of 
admission (figure 3D). 
 
Ethnicity, critical care admission and invasive mechanical ventilation 
Overall, 4,353 patients (14%) were admitted to a critical care facility (figure 4A). On unadjusted analysis, 
White individuals (n=3,258, 13%) were less likely to be admitted to critical care than South Asian (293, 21%), 
East Asian (64, 24%), Black (241, 22%), or Other Ethnic Minority (497, 21%) people.  
In models accounting for age, sex, and location (figure 5B), these associations persisted in South Asian (odds 
ratio 1.28, 95% confidence interval 1.09 to 1.59), Black (1.36, 1.14 to 1.62), and Other Ethnic Minority (1.29, 
1.13 to 1.47) (table E3) groups. No meaningful change in these estimates was seen with the sequential 
introduction of potential mediators including deprivation and comorbidities (diabetes, obesity, chronic 
cardiac disease, non-asthmatic chronic pulmonary disease, chronic kidney disease, and dementia) (figure 
5C).  
Similar findings were found in analyses of invasive mechanical ventilation (Figure E2, table E3).  
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Ethnicity and survival from COVID-19 
In analyses not accounting for age and sex differences between ethnic groups, in-hospital mortality occurred 
more frequently in the White group compared to the Ethnic Minorities (figure 4C, 6A). A sensitivity analysis 
excluding patients admitted in the most recent four weeks showed the same results (figure 4D).  
However, in models accounting for age, sex, and location, evidence of higher mortality was seen in South 
Asian (hazard ratio 1.19, 1.05 to 1.36), but not East Asian (1.00, 0.74 to 1.35), Black (1.05, 0.91 to 1.21) or 
Other Ethnic Minority (0.99, 0.89 to 1.10) groups, compared to White group (figure 6B; table E5). No 
interaction was seen between ethnicity and age nor ethnicity and sex. Similar results were seen in 
alternative models of competing risks (table E10) and in models replaced in the ten multiple imputation sets 
(figure E3).  
All associated comorbidities were explored as potential mediators of the apparent association between 
South Asian ethnicity and an increased hazard of death. Comorbidities associated with death in age- and sex-
adjusted analysis were explored (table E11 to E15). Of these, diabetes (hazard ratio 2.29, 1.99 to 2.62, P < 
0.001) and chronic kidney disease (1.66, 1.38 to 2.00, P < 0.001) had strong positive associations with South 
Asian ethnicity (figure 2).  
A significant mediation effect (total natural indirect) of diabetes was found (hazard ratio 1.03, 1.02 to 1.04, P 
< 0.001; table E16) representing 17.8% (8.9 to 65.7, P = 0.009; table E17) of the total effect of South Asian 
ethnicity on mortality (figure 7). Chronic kidney disease did not contribute significantly beyond the addition 
of diabetes to the model. Finally, to explore the relationship between age, diabetes and South Asian 
ethnicity, a Cox model was fitted including a three-way interaction (Figure 7B). The excess mortality was 
seen only in older South Asian patients. The association between diabetes and mortality was strongest in 
younger patients, compared with older. The diabetes effect was as strong in white patients, but the 
prevalence of diabetes higher in the South Asian group.   
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Discussion 
In this UK prospective cohort of 34,986 patients in hospital with COVID-19, patients from Ethnic Minority 
backgrounds were more likely to be admitted to critical care and to undergo IMV than White people, despite 
there being no difference in disease severity at presentation nor duration of symptoms and being 
substantially younger. South Asians in hospital with COVID-19 were 20% more likely to die than Whites, and 
18% of this increased risk was mediated by higher prevalence of diabetes in the South Asian group. The 
higher risk of death was apparent in older South Asians, while the effect of diabetes was strongest in the 
young. This has significant implications given the younger age and higher prevalence of diabetes in South 
Asians admitted to hospital with COVID-19.  
The ISARIC WHO CCP is the largest prospective observational cohort study of in-hospital patients with 
COVID-19 to date, now accounting for 40% of patients admitted to hospitals in the UK. It is the first study to 
look at in-hospital trajectories between different ethnic groups with COVID-19. We analysed the data with 
several separate approaches and our findings remained consistent. Our study has demonstrated the vital 
importance of forward planning and investment in preparedness studies: we were able to collect granular 
patient data in near-real time, and undertake analyses during the growth phase of the pandemic in the UK, 
without the delay associated with routine healthcare data linkages.  
As this was a cohort of patients already admitted to hospital, we were unable to assess the risk of hospital 
admission or out-of-hospital mortality, leading to a potential risk of selection/collider bias when assessing 
mediators. Our analysis also does not take community factors into account such as population infection 
rates, exposure by employment, dose of exposure, and potential differential infection rates between 
different ethnic groups. Higher infection rates may be the result of bigger families, multi-generational 
households, urban residence, domestic overcrowding, and a greater proportion of individuals in direct 
public-interacting and healthcare occupations. Our analysis was also limited in the measurement of some 
key measures of health inequality: we did not have individual measures of socioeconomic status and had 
limited information on health behaviours such as smoking.  
While we recruited 40% of patients admitted to hospital with COIVD-19, the results may reflect the 
differential risk in the whole hospital COVID-19 population, however we have no information on the 60% of 
patients who were not recruited. Our ethnicity definitions were designed to be broad for ease of data 
collection, but this reduced the ability to capture nuances in ethnicity. This limited our ability to explore 
these in greater depth, meaning that we may have missed differences within smaller groups. The Other 
Ethnic Minority group was likely to be heterogeneous. Obesity was defined by physician assignment and 
recorded as present or absent, rather than as BMI, which may underrepresent obesity in Asian population 
where obesity is defined as BMI greater than 27.5.34 There were significant missing data given the nature of 
collecting prospective data at speed during a pandemic, but analyses of imputed datasets reflect those of 
the complete case analysis.  
Characteristics of ethnic groups going into hospital were different: patients from non-White groups were 
younger and more likely to have diabetes compared with the White group, who were older and had more 
cardiac and respiratory disease. Variation in healthcare seeking behaviours and access to healthcare 
amongst more disadvantaged groups could also contribute to differences in the consequences of COVID-
19,18 however, we found no significant difference between ethnic groups in duration or severity of 
symptoms at hospital presentation in patients who were admitted.  
Although the age-adjusted proportions of patients admitted to critical care was higher in the Ethnic Minority 
group, a large majority of patients admitted to critical care were White (White 75%, South Asian 6.7%, East 
Asian 1.5%, Black 5.5%, Other Ethnic Minority 11.4%). This is a higher proportion compared with the latest 
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ICNARC report, which found a two thirds of patients admitted to critical care were White.19 This may 
represent a selection bias in our cohort, or differences in definitions of critical care.  
As reported in our earlier analysis, extreme elderly age and the presence of comorbidities were associated 
with a lower likelihood of critical care admission, suggesting advanced care planning decisions on the ward.4 
While this may have disproportionately affected patients in the White group who were significantly older 
with more cardiac and respiratory disease, the increased likelihood of critical care admission and IMV in 
Ethnic Minorities persisted after adjustment. This may reflect an increased severity of disease in multiple 
Ethnic Minority populations, but falling short of significantly increased mortality in many. 
Our finding of significantly increased mortality in the South Asian group is in agreement with reports which 
found that people from Asian and Black ethnic groups were at increased risk of in-hospital death from 
COVID-19, and that this was only partially attributable to pre-existing clinical risk factors or deprivation.8,18,35 
We add an important and detailed picture of differences in characteristics of ethnic groups in hospital. The 
prevalence of diabetes is also striking at around 40% in South Asian and Black patients and the mediation of 
the mortality effect by diabetes is important. This appeared independent of chronic cardiac disease and 
chronic kidney disease and is likely to be due to the multitude of other negative health associations carried 
by the condition.  
What of the increased mortality in South Asian patients left unexplained? Our models did not account well 
for wide socioeconomic determinants of outcome, as well as nuance in the comorbidity data. Socioeconomic 
inequalities contribute to differential exposure to infection, differential vulnerability following infection, and 
differential consequences of infection as well as control measures.36 In other studies, at Local Authority 
district level, the districts with a greater proportion of residents from non-White groups experienced higher 
COVID19 mortality rates, as did districts with a greater proportion of residents experiencing deprivation 
from low income.19 We did not find that deprivation at the level of the hospital was a significant predictor of 
time to hospital admission or severity of illness in hospital, however, aggregation of deprivation at hospital 
level masks individual socioeconomic effects. Future studies should examine the disaggregated effects 
where possible. 
Why was excess mortality not apparent among our Black population, as others have reported?8 It seems 
unlikely this group are dying disproportionately in community compared with hospital settings, so any true 
effect should be visible in our cohort. Given that our study includes 40% of the UK hospitalised population, 
selection bias is clearly a possibility. On the other hand, it is possible that the estimates in our study are 
correct, given that some population-level reports rely on older census data as the denominator. Our on-
going work includes linking our dataset widely to better understand the place of the in-hospital stay as part 
of the full patient journey. 
Finally, a subset of our cohort has consented to biological studies that can investigate potential bio-
mechanistic differences in outcomes by ethnicity. Susceptibility to influenza23 is heritable, and it seems likely 
that this is also true for COVID-19.25 Ethnicity correlates with particular genetic polymorphisms which may 
link to important biological mechanisms mediating disease susceptibility and severity, for instance, relating 
to ACE2 receptor expression and SARS-CoV-2 cell entry.26 
Our findings have important implications for policy makers and researchers. Given we illustrate increased 
disease severity across multiple hospitalised Ethnic Minority populations, ethnicity may need to be 
considered in the prioritisation of treatment and future vaccination policy.  South Asians are over-
represented in frontline key worker and other direct public-interacting occupations,37 and policies should 
consider this factor in refining guidance and advice for at-risk individuals, accounting for age and 
comorbidity. On-going work to devise risk assessment tools to help mitigate the likelihood of SARS-CoV-2 
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infection and manage the easing of individual lockdown restrictions needs to consider the effects of ethnicity 
on outcomes. Careful consideration also needs to be given in constructing these tools to the weighting of 
mediators of risk such as diabetes. Further research integrating primary and secondary care data is key to 
improving the understanding of other drivers of poor outcomes in Ethnic Minority patients.    
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Table 1. Characteristics of patients admitted to hospital with COVID-19 during between 6th February 2020 
and 8th May 2020 by ethnic group. P-value is for a comparison across ethnic groups excluding missing data 
and is a chi-squared test for categorical variables and an F-test for continuous variables. Data n (%) unless 
otherwise stated. IMD, index of multiple deprivation. 4,293 missing ethnicity (see table E9).  
Ethnicity  White South Asian East Asian Black 
Other Ethnic 
Minority p 
Total N (%)  25547 (83.2) 1388 (4.5) 266 (0.9) 1094 (3.6) 2398 (7.8)  
Age on admission (years) Mean (SD) 72.3 (15.6) 59.8 (17.4) 60.3 (17.3) 61.4 (17.3) 62.4 (17.8) <0.001 
 18-39 1025 (4.0) 180 (13.0) 32 (12.0) 126 (11.5) 275 (11.5)  
 40-49 1308 (5.1) 243 (17.5) 43 (16.2) 140 (12.8) 336 (14.0)  
 50-59 2962 (11.6) 248 (17.9) 57 (21.4) 273 (25.0) 432 (18.0)  
 60-69 3928 (15.4) 286 (20.6) 43 (16.2) 197 (18.0) 431 (18.0)  
 70-79 6319 (24.7) 222 (16.0) 46 (17.3) 143 (13.1) 430 (17.9)  
 80+ 10005 (39.2) 209 (15.1) 45 (16.9) 215 (19.7) 494 (20.6)  
Sex at Birth Male 14684 (57.5) 887 (63.9) 174 (65.4) 602 (55.0) 1426 (59.5) <0.001 
 Female 10778 (42.2) 500 (36.0) 91 (34.2) 490 (44.8) 964 (40.2)  
 (Missing) 85 (0.3) 1 (0.1) 1 (0.4) 2 (0.2) 8 (0.3)  
Diabetes No 17447 (74.9) 679 (60.6) 169 (70.4) 606 (61.2) 1435 (69.3) <0.001 
 Yes 5838 (25.1) 441 (39.4) 71 (29.6) 384 (38.8) 636 (30.7)  
Obesity No 18952 (74.2) 910 (65.6) 207 (77.8) 804 (73.5) 1718 (71.6) 0.201 
 Yes 2382 (9.3) 114 (8.2) 19 (7.1) 123 (11.2) 210 (8.8)  
 (Missing) 4213 (16.5) 364 (26.2) 40 (15.0) 167 (15.3) 470 (19.6)  
Chronic cardiac disease No 15403 (60.3) 867 (62.5) 195 (73.3) 841 (76.9) 1629 (67.9) <0.001 
 Yes 8228 (32.2) 266 (19.2) 47 (17.7) 162 (14.8) 467 (19.5)  
 (Missing) 1916 (7.5) 255 (18.4) 24 (9.0) 91 (8.3) 302 (12.6)  
Chronic pulmonary disease No 18821 (73.7) 1043 (75.1) 223 (83.8) 929 (84.9) 1857 (77.4) <0.001 
 Yes 4751 (18.6) 86 (6.2) 18 (6.8) 73 (6.7) 218 (9.1)  
 (Missing) 1975 (7.7) 259 (18.7) 25 (9.4) 92 (8.4) 323 (13.5)  
Asthma No 20079 (78.6) 945 (68.1) 207 (77.8) 870 (79.5) 1803 (75.2) 0.108 
 Yes 3358 (13.1) 188 (13.5) 34 (12.8) 129 (11.8) 281 (11.7)  
 (Missing) 2110 (8.3) 255 (18.4) 25 (9.4) 95 (8.7) 314 (13.1)  
Chronic kidney disease No 19201 (75.2) 931 (67.1) 218 (82.0) 831 (76.0) 1796 (74.9) <0.001 
 Yes 4208 (16.5) 193 (13.9) 26 (9.8) 170 (15.5) 286 (11.9)  
 (Missing) 2138 (8.4) 264 (19.0) 22 (8.3) 93 (8.5) 316 (13.2)  
Moderate/severe liver disease No 22739 (89.0) 1102 (79.4) 237 (89.1) 976 (89.2) 2012 (83.9) 0.221 
 Yes 460 (1.8) 13 (0.9) 2 (0.8) 17 (1.6) 37 (1.5)  
 (Missing) 2348 (9.2) 273 (19.7) 27 (10.2) 101 (9.2) 349 (14.6)  
Mild liver disease No 22798 (89.2) 1096 (79.0) 233 (87.6) 979 (89.5) 2006 (83.7) 0.719 
 Yes 344 (1.3) 18 (1.3) 6 (2.3) 13 (1.2) 32 (1.3)  
 (Missing) 2405 (9.4) 274 (19.7) 27 (10.2) 102 (9.3) 360 (15.0)  
Chronic neurological disorder No 20243 (79.2) 1045 (75.3) 221 (83.1) 928 (84.8) 1870 (78.0) <0.001 
 Yes 3032 (11.9) 78 (5.6) 21 (7.9) 68 (6.2) 183 (7.6)  
 (Missing) 2272 (8.9) 265 (19.1) 24 (9.0) 98 (9.0) 345 (14.4)  
Malignancy No 20665 (80.9) 1072 (77.2) 229 (86.1) 915 (83.6) 1910 (79.6) <0.001 
 Yes 2530 (9.9) 48 (3.5) 9 (3.4) 85 (7.8) 144 (6.0)  
 (Missing) 2352 (9.2) 268 (19.3) 28 (10.5) 94 (8.6) 344 (14.3)  
Chronic haematologic disease No 22195 (86.9) 1085 (78.2) 232 (87.2) 922 (84.3) 1971 (82.2) <0.001 
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 Yes 975 (3.8) 33 (2.4) 8 (3.0) 76 (6.9) 80 (3.3)  
 (Missing) 2377 (9.3) 270 (19.5) 26 (9.8) 96 (8.8) 347 (14.5)  
AIDS/HIV No 22931 (89.8) 1092 (78.7) 239 (89.8) 947 (86.6) 2020 (84.2) <0.001 
 Yes 74 (0.3) 4 (0.3) 1 (0.4) 34 (3.1) 9 (0.4)  
 (Missing) 2542 (10.0) 292 (21.0) 26 (9.8) 113 (10.3) 369 (15.4)  
Rheumatologic disorder No 20412 (79.9) 1042 (75.1) 230 (86.5) 936 (85.6) 1899 (79.2) <0.001 
 Yes 2717 (10.6) 67 (4.8) 8 (3.0) 62 (5.7) 141 (5.9)  
 (Missing) 2418 (9.5) 279 (20.1) 28 (10.5) 96 (8.8) 358 (14.9)  
Dementia No 19252 (75.4) 1055 (76.0) 220 (82.7) 933 (85.3) 1872 (78.1) <0.001 
 Yes 4106 (16.1) 60 (4.3) 19 (7.1) 74 (6.8) 193 (8.0)  
 (Missing) 2189 (8.6) 273 (19.7) 27 (10.2) 87 (8.0) 333 (13.9)  
Malnutrition No 21456 (84.0) 1050 (75.6) 225 (84.6) 948 (86.7) 1922 (80.2) 0.031 
 Yes 607 (2.4) 20 (1.4) 5 (1.9) 13 (1.2) 46 (1.9)  
 (Missing) 3484 (13.6) 318 (22.9) 36 (13.5) 133 (12.2) 430 (17.9)  
Smoking Yes 1266 (5.0) 34 (2.4) 9 (3.4) 27 (2.5) 95 (4.0) <0.001 
 Never 
Smoked 
9271 (36.3) 744 (53.6) 142 (53.4) 609 (55.7) 1133 (47.2)  
 Former 
Smoker 
6310 (24.7) 126 (9.1) 34 (12.8) 114 (10.4) 332 (13.8)  
 (Missing) 8700 (34.1) 484 (34.9) 81 (30.5) 344 (31.4) 838 (34.9)  
Prior immunosuppression No 20734 (81.2) 1027 (74.0) 216 (81.2) 907 (82.9) 1906 (79.5) 0.003 
 Yes 2329 (9.1) 88 (6.3) 15 (5.6) 86 (7.9) 173 (7.2)  
 (Missing) 2484 (9.7) 273 (19.7) 35 (13.2) 101 (9.2) 319 (13.3)  
Prior infection treatment No 18342 (71.8) 892 (64.3) 187 (70.3) 817 (74.7) 1672 (69.7) 0.193 
 Yes 4659 (18.2) 216 (15.6) 44 (16.5) 176 (16.1) 389 (16.2)  
 (Missing) 2546 (10.0) 280 (20.2) 35 (13.2) 101 (9.2) 337 (14.1)  
Deprivation (IMD) Mean (SD) 0.1 (0.8) 0.1 (0.8) 0.2 (0.8) 0.1 (0.7) 0.3 (0.7) <0.001 
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Figure 1. Patient inclusion stratified by ethnicity. Critical care use, invasive mechanical ventilation, and 
mortality in all included patients.  
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Figure 2. Age and sex adjusted association between ethnicity and comorbidity for patients in hospital with 
COVID-19. Hierarchical logistic regression models of complete data. Data are odds ratios (95% confidence 
interval, P-value).   
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Figure 3. Severity score at admission and time from symptom onset to admission by ethnicity. National early 
warning score 2 (NEWS2) distribution (A) and proportion with NEWS2 >2 (C) by ethnicity. In patients 
presenting to hospital with COVID-19, distribution of time from symptom onset to admission (B) and Cox 
proportion hazards model of time to admission showing relative hazard for admission by ethnicity adjusted 
for age and sex (D). 
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Figure 4. Unadjusted critical care admission (A), use of invasive mechanical ventilation (B), case fatality in 
patients with at least 2 weeks follow-up (C) and with at least 4 weeks follow-up (D) by ethnicity. Proportions 
from crude counts with no adjustment for age, sex, or clustering. Binomial confidence intervals. Numbers 
are patient counts per group / total cohort (%). IMV, invasive mechanical ventilation. 
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Figure 5. Critical care admission by ethnic group. (A) Univariable logistic regression model of ethnicity alone. 
(B) Hierarchical logistic regression model adjusting for age, sex and accounting for clustering in hospitals. (C) 
Hierarchical logistic regression models with adjustment for factors potentially mediating critical care 
admission were explored sequentially. Full model presented here accepting potential bias in comorbidity 
estimates. Complete case data. See table E3 for full models. Size of point estimate box proportional to 
population size. IMD, index of multiple deprivation (centred and standardised). 
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Figure 6. In-hospital survival by ethnic group. Estimates are hazard ratio (95% confidence interval, P-value). 
(A) Univariable Cox proportional hazards regression model of ethnicity alone. (B) Hierarchical Cox 
proportional hazards regression model adjusting for age, sex and deprivation, accounting for clustering 
within hospital. (C) Hierarchical Cox proportional hazards regression models with adjustment for factors 
potentially mediating survival by ethnic group were explored sequentially. accounting for clustering. Full 
model presented here accepting potential bias in comorbidity estimates. Complete case data. See table E5 
for full models. Size of point estimate box proportional to population size. CI, confidence interval; IMD, index 
of multiple deprivation (centred and standardised). 
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Figure 7. Mediation of apparent excess hazard of death in South Asian group by diabetes. (A) Three-way 
decomposition mediation analysis was performed for comorbidities associated with ethnicity (Figure 2; table 
E11 to E15) and outcome (Figure 7). All models included age and sex as covariates. The proportion of the 
total effect mediated by diabetes for mortality in South Asian patients with bootstrapped 95% CI intervals 
was determined. (B) Cox proportional hazards model of in-hospital mortality including age, sex, ethnicity, 
and diabetes status, including interactions between age, ethnicity, and diabetes. The cumulative probability 
of in-hospital death by day 30 after symptom onset was calculated for the subgroups shown and 95% 
confidence intervals determined by bootstrap resampling of models. See table E18 for full model.   
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Ethnicity
Age on admission (years)
Sex at Birth
White
South Asian
East Asian
Black
Other Ethnic Minority
50-59
18-39
40-49
60-69
70-79
80+
Male
Female
-
1.19 (1.05-1.36, p=0.008)
1.00 (0.74-1.35, p=0.980)
1.05 (0.91-1.21, p=0.500)
0.99 (0.89-1.10, p=0.850)
-
0.30 (0.23-0.40, p<0.001)
0.52 (0.42-0.63, p<0.001)
2.06 (1.84-2.31, p<0.001)
3.44 (3.10-3.82, p<0.001)
4.97 (4.49-5.50, p<0.001)
-
0.76 (0.72-0.79, p<0.001)
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Ethnicity
Age on admission (years)
Sex at Birth
Deprivation (IMD)
Diabetes
Obesity
Chronic cardiac disease
Chronic pulmonary disease
Chronic kidney disease
Dementia
White
South Asian
East Asian
Black
Other Ethnic Minority
50-59
18-39
40-49
60-69
70-79
80+
Female
-
Yes
No
Yes
(Missing)
Yes
Yes
Yes
Yes
-
1.20 (1.05-1.36, p=0.008)
1.02 (0.76-1.38, p=0.890)
1.07 (0.92-1.23, p=0.380)
1.01 (0.91-1.12, p=0.790)
-
0.31 (0.23-0.41, p<0.001)
0.53 (0.43-0.65, p<0.001)
1.98 (1.76-2.22, p<0.001)
3.09 (2.78-3.44, p<0.001)
4.21 (3.79-4.68, p<0.001)
0.76 (0.73-0.80, p<0.001)
1.00 (0.95-1.06, p=0.890)
1.08 (1.03-1.13, p=0.003)
-
1.26 (1.16-1.37, p<0.001)
1.05 (0.97-1.14, p=0.240)
1.13 (1.08-1.18, p<0.001)
1.17 (1.11-1.23, p<0.001)
1.26 (1.20-1.34, p<0.001)
1.33 (1.26-1.41, p<0.001)
-0.50 -0.25 0.00 0.25 0.50
as.numeric(HR)
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Hazard ratio (95% CI, log scale)
  In-patient survival: hierarchical with potential mediators C
This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=3618215
Ethnicity:
South Asian
vs
White
Mortality
Direct effect
HR = 1.14 (1.01 to 1.30)
82%
Diabetes
Indirect effect (mediation by diabetes)
HR = 1.03 (1.02 to 1.04)
18%
Age
Sex
Male Female
40 60 80 40 60 80
20
40
60
80
Age (years)
In
-h
os
pit
al 
m
or
ta
lity
 b
y d
ay
 3
0 
af
te
r s
ym
pt
om
 o
ns
et
 (%
)
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